Keeping our eyes on STAR*D.
Valenstein
Marcia
M
D003511:Cyclohexanols / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008803:Mianserin / Q000031:analogs & derivatives / Q000627:therapeutic use; D000078785:Mirtazapine; D010919:Placebos; D012107:Research Design; D014191:Tranylcypromine / Q000627:therapeutic use; D016896:Treatment Outcome; D014284:Triiodothyronine / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D003692:Delayed-Action Preparations; D010919:Placebos; D014284:Triiodothyronine; D008803:Mianserin; D014191:Tranylcypromine; D000069470:Venlafaxine Hydrochloride; D008094:Lithium; D000078785:Mirtazapine